Changhai Hospital clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   PCP · Endotherapy and/or Extracorporeal Shockwave Lithotripsy for…PCP · Endotherapy and/or Extracorporeal Shockwave Lithotripsy for Painless Chronic Pancreatitis

   Primary completion pushed from Aug 1, 2027 to Dec 1, 2027

   Also in this update: Study completion pushed from Aug 1, 2027 to Jul 1, 2037; Interventions modified

   Changhai Hospital·Not applicable· NCT07074379· Registry history of NCT07074379 on ClinicalTrials.gov (opens the registry)

   Sep 23, 2026

2. Minor

   High-dose Furmonertinib in the Treatment · Advanced, Metastatic…High-dose Furmonertinib in the Treatment · Advanced, Metastatic NSCLC With Progressed After First- or Second-line Treatment With Osimertinib

   Registry marked status Unknown (sponsor has not verified the record since May 2024); last known: Recruiting

   Changhai Hospital·Phase 2· NCT06394674· Registry history of NCT06394674 on ClinicalTrials.gov (opens the registry)

   Changed Oct 4, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.